BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim M, Laramy JK, Gampa G, Parrish KE, Brundage R, Sarkaria JN, Elmquist WF. Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy. Drug Metab Dispos 2019;47:1403-14. [PMID: 31619389 DOI: 10.1124/dmd.119.088716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chowdhury EA, Noorani B, Alqahtani F, Bhalerao A, Raut S, Sivandzade F, Cucullo L. Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview. J Cereb Blood Flow Metab 2021;41:1797-820. [PMID: 33444097 DOI: 10.1177/0271678X20985946] [Reference Citation Analysis]
2 Rathi S, Griffith JI, Zhang W, Zhang W, Oh JH, Talele S, Sarkaria JN, Elmquist WF. The influence of the blood-brain barrier in the treatment of brain tumours. J Intern Med 2022. [PMID: 35040235 DOI: 10.1111/joim.13440] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Buchsbaum JC, Coleman CN, Bernhard EJ, Espey MG, Vikram B. Overview and Lessons From the Preclinical Chemoradiotherapy Testing Consortium. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)02622-5. [PMID: 34348172 DOI: 10.1016/j.ijrobp.2021.07.1709] [Reference Citation Analysis]
4 Ashrafizadeh M, Zarrabi A, Hushmandi K, Kalantari M, Mohammadinejad R, Javaheri T, Sethi G. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. Int J Mol Sci 2020;21:E4002. [PMID: 32503307 DOI: 10.3390/ijms21114002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 19.0] [Reference Citation Analysis]
5 Vuaroqueaux V, Hendriks HR, Al-Hasani H, Peille AL, Das S, Fiebig HH. Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers. NPJ Precis Oncol 2021;5:96. [PMID: 34711913 DOI: 10.1038/s41698-021-00235-7] [Reference Citation Analysis]